1. Dr. Lal Path Labs
stock logo

63% Sell

Dr. Lal Path Labs Share Price

LALPATHLAB

₹2,998.00+₹1.15 (0.04%) TodayLast updated on 16 Jul, 2024 | 15:53 IST
₹2,955.35₹3,020.50
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • F&O (Option chain)

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹24,556 Crs

Open

₹3,005.00

Close

₹2,996.85

Circuit range

₹3,296.50 - ₹2,697.20

Day range

₹2,955.35 - ₹3,020.50

Year range

₹1,943.70 - ₹3,055.00

Volume

3,08,256

Avg. traded

₹2,996.34

Revenue (12m)

₹2,227 Crs

Dr. Lal Path LabsDr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Dr. Lal Path Labs Key indicators

arrow

52 week high

₹3,055.00

52 week low

₹1,943.70

P/E ratio

69.73

P/B ratio

13.7

ROE

22.09%

ROCE

27.77%

Dividend yield

0.8%

Debt/Equity ratio

0.05

EPS

46.04

Learn more

Investment checklist: (4/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Sell

arrow

Buy

25%

Hold

12%

Sell

63%

This analysis is based on the reviews of 16 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

31.49%

Net profit margin

19.54%

ROE

22.09%

ROA

16.48%

ROCE

27.77%

Learn more

Dr. Lal Path Labs Shareholder returns

arrow

1 day

+1.56%

1 week

+3.11%

1 month

+8.97%

3 months

+29.17%

1 year

+27.17%

3 years

-12.59%

5 years

+184.49%

Dr. Lal Path Labs Share Price history

arrow
DayOpenCloseDay’s change
Mon, Jul 15 2024
₹2,975.00
₹2,996.85
+1.56%
Fri, Jul 12 2024
₹2,946.35
₹2,950.85
+0.15%
Thu, Jul 11 2024
₹2,960.95
₹2,946.35
-0.08%
Wed, Jul 10 2024
₹2,933.50
₹2,948.70
+0.81%
Tue, Jul 9 2024
₹2,934.00
₹2,925.15
+0.65%
Mon, Jul 8 2024
₹2,889.60
₹2,906.40
+0.74%
Fri, Jul 5 2024
₹2,926.85
₹2,885.00
-0.74%
Thu, Jul 4 2024
₹2,837.45
₹2,906.65
+3.03%

Shareholding info

arrow

Promoters (54.6%)

Mutual Funds (9.3%)

Retail and other (7.26%)

Foreign institutions-FII (25.43%)

Other domestic institutions (3.4%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹6/share

    Ex date 10 Jun 2024

    expand tab
  • Dividend • ₹12/share

    Ex date 13 Feb 2024

    expand tab
  • Dividend • ₹6/share

    Ex date 11 Aug 2023

    expand tab
  • Dividend • ₹6/share

    Ex date 11 Aug 2023

    expand tab
  • Dividend • ₹6/share

    Ex date 05 Aug 2022

    expand tab
  • Dividend • ₹6/share

    Ex date 22 Jun 2022

    expand tab

Learn more

Frequently asked questions